Clinical Trials Logo

Clinical Trial Summary

An adequate fiber intake is crucial for a well-balanced diet and reduces the risk of chronic diseases. However, nutritional recommendations for chronic kidney disease patients lead to an insufficient fiber intake with possible maladaptive effects on the gut microbiome. Therefore, we want to study the effects of a 28-day inulin supplementation on the gut microbiome, gut barrier function, bacterial metabolites and immune cell states in chronic kidney disease patients.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05071131
Study type Interventional
Source Charite University, Berlin, Germany
Contact Victoria McParland, PhD
Phone +49 30 450 540 464
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date October 1, 2021
Completion date October 1, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04805632 - Immune Response in Dialysis Patients Vaccinated Against COVID-19